慢加急性肝衰竭“毒浊致病”学说的科学内涵及其代表方解毒化瘀Ⅱ方的临床应用  

Scientific connotation of"toxic turbidity causing disease"theory in acute-on-chronic liver failure and the clinical application of its representative formula,Jiedu Huayu FormulaⅡ

作　　者：封佩佩 石清兰[2] 毛德文[2] 杨敏 杨钒 陶向君 黄乾铭 赵青青 潘秋和 FENG Peipei;SHI Qinglan;MAO Dewen;YANG Min;YANG Fan;TAO Xiangjun;HUANG Qianming;ZHAO Qingqing;PAN Qiuhe(Guangxi University of Chinese Medicine,Nanning,Guangxi 530000,China;The First Hospital of Guangxi University of Chinese Medicine,Nanning,Guangxi 530000,China)

机构地区：[1]广西中医药大学,广西南宁530000 [2]广西中医药大学第一附属医院,广西南宁530000

出　　处：《湖南中医药大学学报》2024年第7期1298-1303,共6页Journal of Hunan University of Chinese Medicine

基　　金：国家自然科学基金项目(82060847);第五批全国中医临床优秀人才研修项目(国中医药人教函[2022]1号)。

摘　　要：慢加急性肝衰竭“毒浊致病”学说是毛德文教授团队在急性肝衰竭“毒邪致病”学说基础上提炼而来。本文详细介绍慢加急性肝衰竭“毒浊致病”学说的形成、科学内涵及其对中医临床实践的指导意义,充分阐述慢加急性肝衰竭“毒浊致病”学说的科学性及其代表方解毒化瘀Ⅱ方治疗慢加急性肝衰竭的可行性及确切疗效。The theory of"toxic turbidity causing disease"in acute-on-chronic liver failure(ACLF)is refined by Professor MAO Dewen's team based on the theory of"toxic pathogen causing disease"in acute liver failure.This paper provides a detailed introduction to the formation and scientific connotation of the"toxic turbidity causing disease"theory in ACLF,as well as its guiding significance for clinical practice of Chinese medicine.Moreover,it fully elucidates the scientific nature of the"toxic turbidity causing disease"theory in ACLF and the feasibility and definite efficacy of its representative formula,Jiedu Huayu FormulaⅡ.

关 键 词：慢加急性肝衰竭 毒浊致病 解毒化瘀Ⅱ方 医案举隅 毛德文 

分 类 号：R256.4[医药卫生—中医内科学]